University College London (UCL) has submitted a planning application for its exciting proposals for a new world-class centre for neurological research and treatments. The centre will bring together clinicians and research teams from different disciplines to tackle the neurodegenerative conditions that give rise to dementia, now the leading cause of death in England and Wales.
The new biomedical facility at 256 Gray’s Inn Road will host the central hub of UK Dementia Research Institute (UK DRI) and the University’s leading Queen Square Institute of Neurology (IoN), which will include an NHS Neurology out-patient facility for University College London Hospitals. Our aim is to provide the most comprehensive, coordinated neuroscience research centre in the world; from research at laboratory benches to patient care.
We are also proposing the refurbishment of the Grade II listed Eastman Dental Clinic and the creation of a new building on the current site of the Levy Wing to deliver additional academic space for UCL. This academic space is likely to be occupied by the newly established UCL Institute of Mathematics and Statistical Science, which will complement the University’s vision for creating a world class environment for education and academic research. This will further strengthen London’s cluster of academic institutions, which form part of its Knowledge Quarter, while also collaborating with the dementia and neurology research centre.
About neurological illness:
· Disabling neurological diseases, such as dementia, stroke and epilepsy, affect four million people in the UK
· They account for about 13% of global disease prevalence
· More people live with neurological disease than cardiovascular disease and cancer
· In Camden, 1,256 people aged over 65 were diagnosed with dementia in 2016 alone
· The annual cost to the UK Economy is estimated to be £112 billion.